Immunome, Inc. (IMNM) came out with a quarterly loss of $0.78 per share versus the Zacks Consensus Estimate of a loss of $0.60. This compares to loss of $0.36 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of -30%. A quarter ago, it was expected that this company would post a loss of $0.38 per share when it actually produced a loss of $0.49, delivering a surprise of -28.95%.Over the last four quarters, the company has surpassed ...